Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
» Could pain data give Lilly's baricitinib back its edge?
Could pain data give Lilly's baricitinib back its edge?
Could pain data give Lilly's baricitinib back its edge?
Submitted by
admin
on November 7, 2017 - 9:48am
Source:
BioPharma Dive
News Tags:
Eli Lilly
baricitinib
Humira
AbbVie
rheumatoid arthritis
Headline:
Could pain data give Lilly's baricitinib back its edge?
